BEIJING, March 13, 2024/PRNewswire/ -- Shanggao Corporation (hereinafter referred to as “Shanggao” or the “Company”; NASDAQ: SISI; a technologically advanced healthcare products and services provider) announced today that Shanggao received a letter from the NASDAQ Stock Market Co., Ltd. (“NASDAQ”) listing eligibility department on March 11, 2024 confirming that the company has once again complied with the minimum bid price rule stipulated in NASDAQ Listing Rule 5550 (a) (2) because the closing price of Shanggao's common stock was at or for 15 consecutive working days Above $1.00. As a result, the company has re-complied with NASDAQ listing rules, and NASDAQ believes this matter is over.
About Shanggao
Shanggao aims to “care for a healthy life and improve the quality of life” to provide safe, efficient and high-quality health products and services to the community. Currently, it develops and manufactures 33 kinds of in vitro diagnostic reagents and related medical devices, and is engaged in the production and sale of health foods and health foods. For more information about Shanggao, please visit.
Forward-looking statements
This press release contains “forward-looking statements” within the meaning of section 27A of the 1933 Securities Act as amended and section 21E of the 1934 Securities Exchange Act as amended. These forward-looking statements are expressed using “may,” “will,” “should,” “intend,” “anticipate,” “plan,” “budget,” “forecast,” “believe,” “estimate,” “potential,” “continue,” “evaluate,” or similar terms. We remind you not to rely too much on these forward-looking statements, as they are neither objective facts nor guarantees of future results. These statements are based solely on our current expectations and assumptions about the future development of the business, future plans and strategies, anticipated events and trends, economic conditions, and other future conditions. You are reminded not to rely too much on these forward-looking statements. Actual results may differ materially from historical results or those indicated in these forward-looking statements due to various factors, including but not limited to its ability to raise additional capital, its ability to maintain and grow its business, its ability to maintain and enhance its brand, develop and launch new products and services, successfully integrate acquired companies, technology and assets into its product and service portfolio, marketing and other business development initiatives, industry competition, general government regulation, economic conditions, the impact of the COVID-19 pandemic, and the satisfaction of attracting, hiring, and retaining key personnel Customers require personnel with the required technical skills and experience, as well as the ability to protect their intellectual property rights. SCC encourages you to review other factors that may affect its future results in its registration statement and other filings with the U.S. Securities and Exchange Commission. The forward-looking statements in this press release are based on current expectations and were published only on the date of publication of this press release, and SCM undertakes no obligation to update these forward-looking statements.
For more information, please contact:
Shineco, Inc.
E-mail: secretary@shineco.tech
Phone: +86-010-68130220
Precept Investor Relations LLC
David J. Rudnick
E-mail: david.rudnick@preceptir.com
Phone: +1 646-694-8538